Process View
Any process that decreases the rate, frequency, or extent of gene silencing by RNA. Gene silencing by RNA is the process in which RNA molecules inactivate expression of target genes.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of gene silencing by rna"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| FOXD3 | forkhead box D3 | 0.997 | ||
| WWP2 | WW domain containing E3 ubiquitin protein ligase 2 | 0.991 | ||
| SP1 | Sp1 transcription factor | 0.957 | ||
| SOX10 | SRY (sex determining region Y)-box 10 | 0.905 | ||
| HCFC1 | host cell factor C1 (VP16-accessory protein) | 0.891 | ||
| SOX2 | SRY (sex determining region Y)-box 2 | 0.874 | ||
| PAX3 | paired box 3 | 0.816 | ||
| EIF2AK2 | eukaryotic translation initiation factor 2-alpha kinase 2 | 0.737 | ||
| DAZL | deleted in azoospermia-like | 0.683 | ||
| TARDBP | TAR DNA binding protein | 0.533 | ||
| PUM2 | pumilio homolog 2 (Drosophila) | 0.518 | ||
| IRF9 | interferon regulatory factor 9 | 0.352 | ||
| UPF1 | UPF1 regulator of nonsense transcripts homolog (yeast) | 0.297 | ||
| MOCS3 | molybdenum cofactor synthesis 3 | 0.295 | ||
| PARP12 | poly (ADP-ribose) polymerase family, member 12 | 0.191 | ||
| EXOSC10 | exosome component 10 | 0.175 | ||
| TOP1 | topoisomerase (DNA) I | 0.170 | ||
| MEOX2 | mesenchyme homeobox 2 | 0.122 | ||
| HMGA1 | high mobility group AT-hook 1 | 0.115 | ||
| GABPA | GA binding protein transcription factor, alpha subunit 60kDa | 0.112 | ||
| HNRNPU | heterogeneous nuclear ribonucleoprotein U (scaffold attachment factor A) | 0.080 | ||
| DHX9 | DEAH (Asp-Glu-Ala-His) box polypeptide 9 | 0.073 | ||
| SMAD7 | SMAD family member 7 | 0.061 | ||
| SH3RF3 | SH3 domain containing ring finger 3 | 0.056 | ||
| NR0B1 | nuclear receptor subfamily 0, group B, member 1 | 0.044 | ||
| CSNK2B | casein kinase 2, beta polypeptide | 0.043 | ||
| XPO7 | exportin 7 | 0.042 | ||
| SOX1 | SRY (sex determining region Y)-box 1 | 0.041 | ||
| POU3F3 | POU class 3 homeobox 3 | 0.038 | Human | |
| PABPC1 | poly(A) binding protein, cytoplasmic 1 | 0.037 | ||
| HTT | huntingtin | 0.037 | ||
| SOX11 | SRY (sex determining region Y)-box 11 | 0.035 | ||
| RAC1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) | 0.034 | ||
| POU3F2 | POU class 3 homeobox 2 | 0.031 | Human | |
| ADARB1 | adenosine deaminase, RNA-specific, B1 | 0.031 | ||
| NKX2-1 | NK2 homeobox 1 | 0.030 | ||
| CSNK2A2 | casein kinase 2, alpha prime polypeptide | 0.029 | ||
| PSME1 | proteasome (prosome, macropain) activator subunit 1 (PA28 alpha) | 0.026 | ||
| HRK | harakiri, BCL2 interacting protein (contains only BH3 domain) | 0.026 | ||
| OTP | orthopedia homeobox | 0.026 | ||
| ZBTB17 | zinc finger and BTB domain containing 17 | 0.024 | ||
| NFYA | nuclear transcription factor Y, alpha | 0.024 | ||
| USP10 | ubiquitin specific peptidase 10 | 0.024 | ||
| SOX21 | SRY (sex determining region Y)-box 21 | 0.024 | ||
| HOXD12 | homeobox D12 | 0.023 | ||
| DZIP1 | DAZ interacting protein 1 | 0.023 | ||
| UPF2 | UPF2 regulator of nonsense transcripts homolog (yeast) | 0.022 | ||
| FOXE1 | forkhead box E1 (thyroid transcription factor 2) | 0.022 | ||
| XRCC5 | X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining) | 0.021 | ||
| IFIT1 | interferon-induced protein with tetratricopeptide repeats 1 | 0.021 | ||
| DICER1 | dicer 1, ribonuclease type III | 0.021 | ||
| KIAA0100 | KIAA0100 | 0.020 | ||
| LHX1 | LIM homeobox 1 | 0.020 | ||
| POU4F1 | POU class 4 homeobox 1 | 0.020 | Human | |
| PRKRA | protein kinase, interferon-inducible double stranded RNA dependent activator | 0.020 | ||
| PURB | purine-rich element binding protein B | 0.019 | ||
| MOV10 | Mov10, Moloney leukemia virus 10, homolog (mouse) | 0.019 | ||
| CSNK1G2 | casein kinase 1, gamma 2 | 0.019 | ||
| DTX3L | deltex 3-like (Drosophila) | 0.018 | ||
| VASP | vasodilator-stimulated phosphoprotein | 0.018 | ||
| NEUROG3 | neurogenin 3 | 0.018 | ||
| POU3F1 | POU class 3 homeobox 1 | 0.018 | Human | |
| NONO | non-POU domain containing, octamer-binding | 0.018 | ||
| STK24 | serine/threonine kinase 24 | 0.017 | ||
| NOVA2 | neuro-oncological ventral antigen 2 | 0.017 | ||
| DHX8 | DEAH (Asp-Glu-Ala-His) box polypeptide 8 | 0.017 | ||
| FBXL15 | F-box and leucine-rich repeat protein 15 | 0.017 | ||
| MEX3B | mex-3 homolog B (C. elegans) | 0.016 | ||
| ASCL1 | achaete-scute complex homolog 1 (Drosophila) | 0.016 | ||
| CYFIP2 | cytoplasmic FMR1 interacting protein 2 | 0.016 | ||
| HNRNPM | heterogeneous nuclear ribonucleoprotein M | 0.016 | ||
| OLIG2 | oligodendrocyte lineage transcription factor 2 | 0.016 | ||
| CHN2 | chimerin (chimaerin) 2 | 0.016 | ||
| POU3F4 | POU class 3 homeobox 4 | 0.016 | Human | |
| CHD8 | chromodomain helicase DNA binding protein 8 | 0.015 | ||
| DDX3X | DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked | 0.015 | ||
| TP73 | tumor protein p73 | 0.015 | ||
| HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C | 0.014 | ||
| PAK1 | p21 protein (Cdc42/Rac)-activated kinase 1 | 0.014 | ||
| PCBP2 | poly(rC) binding protein 2 | 0.014 | ||
| ESR1 | estrogen receptor 1 | 0.014 | ||
| SALL2 | sal-like 2 (Drosophila) | 0.014 | ||
| TLX2 | T-cell leukemia homeobox 2 | 0.014 | ||
| SH3RF1 | SH3 domain containing ring finger 1 | 0.014 | ||
| PRKDC | protein kinase, DNA-activated, catalytic polypeptide | 0.014 | ||
| COMT | catechol-O-methyltransferase | 0.013 | ||
| OCRL | oculocerebrorenal syndrome of Lowe | 0.013 | ||
| ZNF143 | zinc finger protein 143 | 0.013 | ||
| CHD4 | chromodomain helicase DNA binding protein 4 | 0.013 | ||
| THRAP3 | thyroid hormone receptor associated protein 3 | 0.013 | ||
| TFAP2B | transcription factor AP-2 beta (activating enhancer binding protein 2 beta) | 0.012 | ||
| PDAP1 | PDGFA associated protein 1 | 0.012 | ||
| CUL1 | cullin 1 | 0.012 | ||
| MKRN1 | makorin ring finger protein 1 | 0.012 | ||
| CSNK2A1 | casein kinase 2, alpha 1 polypeptide | 0.012 | ||
| TRIM39 | tripartite motif containing 39 | 0.012 | ||
| NKX2-8 | NK2 homeobox 8 | 0.012 | ||
| FAM120A | family with sequence similarity 120A | 0.012 | ||
| NPAS1 | neuronal PAS domain protein 1 | 0.012 | ||
| HTR7 | 5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled) | 0.012 | ||
| HOXB13 | homeobox B13 | 0.011 | ||
| VSX1 | visual system homeobox 1 | 0.011 | ||
| SLC6A2 | solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 | 0.011 | ||
| ATN1 | atrophin 1 | 0.011 | ||
| C20orf11 | chromosome 20 open reading frame 11 | 0.011 | ||
| NHLH2 | nescient helix loop helix 2 | 0.011 | ||
| C19orf6 | chromosome 19 open reading frame 6 | 0.011 | ||
| NKX2-2 | NK2 homeobox 2 | 0.011 | ||
| DCX | doublecortin | 0.011 | ||
| ST8SIA2 | ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 2 | 0.011 | ||
| YTHDF1 | YTH domain family, member 1 | 0.011 | ||
| OSBP | oxysterol binding protein | 0.011 | ||
| RNF4 | ring finger protein 4 | 0.011 | ||
| PAX6 | paired box 6 | 0.011 | ||
| NKX6-1 | NK6 homeobox 1 | 0.011 | ||
| NCL | nucleolin | 0.011 | ||
| TAF4 | TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa | 0.011 | ||
| SALL3 | sal-like 3 (Drosophila) | 0.011 | ||
| CASC3 | cancer susceptibility candidate 3 | 0.011 | ||
| FOXB1 | forkhead box B1 | 0.010 | ||
| NHLH1 | nescient helix loop helix 1 | 0.010 | ||
| PAX2 | paired box 2 | 0.010 | ||
| FMR1 | fragile X mental retardation 1 | 0.010 | ||
| HOXD3 | homeobox D3 | 0.010 | ||
| PAX5 | paired box 5 | 0.010 | ||
| NELL1 | NEL-like 1 (chicken) | 0.010 | ||
| FCER2 | Fc fragment of IgE, low affinity II, receptor for (CD23) | 0.010 | ||
| CD22 | CD22 molecule | 0.010 | ||
| MYCN | v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian) | 0.010 | ||
| RNF114 | ring finger protein 114 | 0.010 |